Labgenomics Faces Kosdaq Delisting Risk Over Minimum Share-Price Requirement

• Labgenomics faces delisting following its Aug. 13, 2026, designation for closing below KRW 1,000 for 30 consecutive trading days.
• Kosdaq rules require 45 consecutive closes at or above KRW 1,000 within 90 trading days of designation to avoid delisting.
• As of Nov. 6, 41 trading days had elapsed since designation, with 29 consecutive closes meeting the threshold.
• A close below KRW 1,000 from the 46th trading day following designation could trigger delisting.
• Reaching 45 consecutive qualifying closes could allow removal of the designation.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Labgenomics Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261106900983), on November 06, 2026, and is solely responsible for the information contained therein.